艾滋病合并丙型肝炎的抗病毒治疗临床观察

目的:观察艾滋病合并丙型肝炎的抗病毒治疗效果并回顾总结艾滋病合并丙肝的临床研究进展。方法:选择艾滋病合并丙型肝炎的患者33例,采用HAART疗法及干扰素联合利巴韦林治疗的方法,治疗4周后观察以上患者谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酸脱氢酶(GLDH)、总胆红素(TBIL)、白蛋白(ALB)和HCV-RNA检查结果,同时总结艾滋病合并丙肝的临床研究进展。结果:治疗4周后,以上患者ALT、AST、GLDH、TBIL、ALB和HCV-RNA阳性患者显著改善,治疗前后比较差异具有(高度)统计学意义(P<0.05,P<0.01)。结论:在对艾滋病合并丙型肝炎充分了解的同时,积极采取抗病毒治疗措施,可延缓疾病的发展。

The Antiviral Therapy Observation and ClinicalResearch of AIDS Combined Hepatitis C

Objective: To observe the clinical effect of antiviral therapy for the AIDS combined hepatitis C and summarize the clinical research.Method: Collect 33 patients with AIDS combined hepatitis C,they were treated by the HAART,IFN and Ribavirin,then observe the ALT,AST,GLDH,TBIL,ALB and HCV-RNA check after 4 weeks’ treatment,then summarize the clinical research.Result: There was a(highly) statistical significant difference(P<0.05,P<0.01) in the aspects.Conclusion: When we fully understand the AIDS combined hepatitis C,we should take the anti-viral treatment,it could delay the development of the disease.